| MicroRNA: A novel target of curcumin in cancer therapy H Mirzaei, A Masoudifar, A Sahebkar, N Zare, J Sadri Nahand, B Rashidi, ... Journal of cellular physiology 233 (4), 3004-3015, 2018 | 252 | 2018 |
| The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial HR Rahimi, AH Mohammadpour, M Dastani, MR Jaafari, K Abnous, ... Avicenna journal of phytomedicine 6 (5), 567, 2016 | 243 | 2016 |
| Perspective of Fe3O4 Nanoparticles Role in Biomedical Applications MR Ghazanfari, M Kashefi, SF Shams, MR Jaafari Biochemistry research international 2016, 2016 | 242 | 2016 |
| Long‐term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans M Balali‐Mood, M Hefazi, M Mahmoudi, E Jalali, D Attaran, M Maleki, ... Fundamental & clinical pharmacology 19 (6), 713-721, 2005 | 241 | 2005 |
| Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes M Iranshahi, P Arfa, M Ramezani, MR Jaafari, H Sadeghian, C Bassarello, ... Phytochemistry 68 (4), 554-561, 2007 | 232 | 2007 |
| Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo Z Naseri, RK Oskuee, MR Jaafari, M Forouzandeh Moghadam International journal of nanomedicine, 7727-7747, 2018 | 204 | 2018 |
| Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration M Abrishami, SZ Ganavati, D Soroush, M Rouhbakhsh, MR Jaafari, ... Retina 29 (5), 699-703, 2009 | 203 | 2009 |
| MicroRNA: relevance to stroke diagnosis, prognosis, and therapy H Mirzaei, F Momeni, L Saadatpour, A Sahebkar, M Goodarzi, ... Journal of cellular physiology 233 (2), 856-865, 2018 | 195 | 2018 |
| Enhancement of follicular delivery of finasteride by liposomes and niosomes: 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models M Tabbakhian, N Tavakoli, MR Jaafari, S Daneshamouz International journal of pharmaceutics 323 (1-2), 1-10, 2006 | 186 | 2006 |
| MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma H Mirzaei, S Gholamin, S Shahidsales, A Sahebkar, MR Jaafari, ... European journal of cancer 53, 25-32, 2016 | 185 | 2016 |
| Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin L Arabi, A Badiee, F Mosaffa, MR Jaafari Journal of controlled release 220, 275-286, 2015 | 175 | 2015 |
| CD47: role in the immune system and application to cancer therapy SMG Hayat, V Bianconi, M Pirro, MR Jaafari, M Hatamipour, A Sahebkar Cellular Oncology 43, 19-30, 2020 | 155 | 2020 |
| Diagnostic and therapeutic potential of exosomes in cancer: the beginning of a new tale? H Mirzaei, A Sahebkar, MR Jaafari, M Goodarzi, HR Mirzaei Journal of cellular physiology 232 (12), 3251-3260, 2017 | 151 | 2017 |
| Circulating microRNAs in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers H Reza Mirzaei, A Sahebkar, M Mohammadi, R Yari, H Salehi, ... Current pharmaceutical design 22 (34), 5257-5269, 2016 | 151 | 2016 |
| Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery Z Huang, MR Jaafari, FC Szoka Jr Angewandte Chemie 121 (23), 4210-4213, 2009 | 138 | 2009 |
| Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo SH Jalalian, SM Taghdisi, NS Hamedani, SAM Kalat, P Lavaee, ... European Journal of Pharmaceutical Sciences 50 (2), 191-197, 2013 | 137 | 2013 |
| Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues R Vakili-Ghartavol, AA Momtazi-Borojeni, Z Vakili-Ghartavol, ... Artificial Cells, Nanomedicine, and Biotechnology 48 (1), 443-451, 2020 | 134 | 2020 |
| Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB/c mice H Ghaffari-Nazari, J Tavakkol-Afshari, MR Jaafari, ... PloS one 10 (11), e0142563, 2015 | 131 | 2015 |
| Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis M Mashreghi, H Azarpara, MR Bazaz, A Jafari, A Masoudifar, H Mirzaei, ... Journal of cellular physiology 233 (4), 2949-2965, 2018 | 129 | 2018 |
| Epi-drugs and Epi-miRs: moving beyond current cancer therapies R Salarinia, A Sahebkar, M Peyvandi, H Reza Mirzaei, M Reza Jaafari, ... Current cancer drug targets 16 (9), 773-788, 2016 | 128 | 2016 |
